Hypertensive crisis in children: an experience in a single tertiary care center in Korea

Geum Hwa Lee1, I Re Lee1, Se Jin Park2

  • 1Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

Clinical Hypertension
|April 20, 2016
PubMed

Insights

Hypertensive crisis in children is often caused by kidney disease or cancer. Nicardipine and labetalol are effective intravenous drugs for managing this condition, showing similar blood pressure reduction and clinical outcomes.

Area of Science:

  • Pediatric Nephrology
  • Pediatric Cardiology
  • Pediatric Oncology

Background:

  • Hypertensive crisis is a critical medical condition with potential for severe end-organ damage.
  • Etiology, treatment, and outcomes of hypertensive crisis in Korean children remain under-researched.
  • This study investigates the causes and drug efficacy for hypertensive crisis in pediatric patients in Korea.

Purpose of the Study:

  • To identify the primary etiologies of hypertensive crisis in Korean children.
  • To evaluate the effectiveness of various intravenous antihypertensive drugs.
  • To compare outcomes between hypertensive emergency and urgency in pediatric patients.

Main Methods:

  • Retrospective analysis of 51 children diagnosed with hypertensive crisis (2010-2014).
  • Patients categorized into hypertensive emergency (n=31) and hypertensive urgency (n=20) groups.
  • Comparison of baseline etiologies, risk factors, and blood pressure response to intravenous antihypertensives.

Main Results:

  • Kidney injury and cancer were identified as common underlying causes.
  • Cardiovascular, central nervous system, and retinal complications were more prevalent in hypertensive emergency.
  • Hydralazine was initially used but often ineffective; nicardipine, labetalol, or nitroprusside were subsequently administered in 45.1% of cases.
  • Nicardipine and labetalol demonstrated comparable efficacy in reducing blood pressure and improving clinical outcomes.

Conclusions:

  • Children with underlying renal diseases and cancer require vigilant blood pressure monitoring and examination.
  • Nicardipine and labetalol are effective options for intravenous management of hypertensive crisis in pediatric populations.
  • Further research into pediatric hypertensive crisis management is warranted.
Abstract

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
639